Rifamycin Drug-Drug Interactions: A Guide for Primary Care Providers Treating Latent Tuberculosis Infection
An online guide to clarify drug interactions between rifamycins and drugs commonly used in primary care. This is meant for primary care and other health professionals.
Author:
The State of California Department of Public Health, Tuberculosis Control Branch (CDPH), the Rutgers Ernest Mario School of Pharmacy (EMSOP), the Rutgers Global Tuberculosis Institute (GTBI), and the Curry International Tuberculosis Center (CITC)
Audiences:
Physicians, Nurses
Topic:
Treatment - Latent TB infection (Inactive TB), Treatment- TB Disease
Country of Origin:
United States
Global resources for the prevention,
management, and elimination of TB.